<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[+ mulig topline data fra de første daratumumab phase III studier (hvis vi er heldige)]]></title><description><![CDATA[<ul>
<li>mulig topline data fra de første daratumumab phase III studier (hvis vi er heldige)</li>
</ul>
]]></description><link>https://dev.proinvestor.com/forum/topic/449123/mulig-topline-data-fra-de-frste-daratumumab-phase-iii-studier-hvis-vi-er-heldige</link><generator>RSS for Node</generator><lastBuildDate>Tue, 09 Jun 2026 22:29:22 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/449123.rss" rel="self" type="application/rss+xml"/><pubDate>Tue, 07 Aug 2012 06:04:27 GMT</pubDate><ttl>60</ttl></channel></rss>